BCL2 and acute lymphoblastic leukemia: Consistent with our findings, an earlier study showed that MLL-ALL cell lines express high levels of Bcl-2 proteins and these cell lines as well as patient-derived MLL-ALL xenografts were highly sensitive to the Bcl-2 inhibitor ABT-199 [55].